SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-19-040399
Filing Date
2019-08-16
Accepted
2019-08-16 16:01:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tv527768_sc13d.htm SC 13D 61308
  Complete submission text file 0001144204-19-040399.txt   62819
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90737 | Film No.: 191033345
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIKING HOUSE NELSON ST. DOUGLAS Y8 IM1 2AH
Business Address CRAIGMUIR CHAMBERS PO BOX 71 ROAD TOWN, TORTOLA D8 VG1110 441624639396
Juvenescence Ltd (Filed by) CIK: 0001724307 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13D